Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Efficacy and safety of adjunctive armodafinil in adults with major depressive episodes associated with bipolar I disorder: a randomized, double-blind, placebo-controlled, multicenter trial.

Calabrese JR, Frye MA, Yang R, Ketter TA; Armodafinil Treatment Trial Study Network.

J Clin Psychiatry. 2014 Oct;75(10):1054-61. doi: 10.4088/JCP.13m08951.

PMID:
25099397
2.

Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects.

Aaronson ST, Carpenter LL, Conway CR, Reimherr FW, Lisanby SH, Schwartz TL, Moreno FA, Dunner DL, Lesem MD, Thompson PM, Husain M, Vine CJ, Banov MD, Bernstein LP, Lehman RB, Brannon GE, Keepers GA, O'Reardon JP, Rudolph RL, Bunker M.

Brain Stimul. 2013 Jul;6(4):631-40. doi: 10.1016/j.brs.2012.09.013. Epub 2012 Oct 23.

PMID:
23122916
3.

Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized study.

Bortnick B, El-Khalili N, Banov M, Adson D, Datto C, Raines S, Earley W, Eriksson H.

J Affect Disord. 2011 Jan;128(1-2):83-94. doi: 10.1016/j.jad.2010.06.031. Epub 2010 Aug 6.

PMID:
20691481
4.

The incremental shuttle walk test in older Brazilian adults.

J├╝rgensen SP, Antunes LC, Tanni SE, Banov MC, Lucheta PA, Bucceroni AF, Godoy I, Dourado VZ.

Respiration. 2011;81(3):223-8. doi: 10.1159/000319037. Epub 2010 Jul 17.

5.

A simple approach to assess VT during a field walk test.

Dourado VZ, Banov MC, Marino MC, de Souza VL, Antunes LC, McBurnie MA.

Int J Sports Med. 2010 Oct;31(10):698-703. doi: 10.1055/s-0030-1255110. Epub 2010 Jul 8.

PMID:
20617483
6.

Long-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder.

Weisler R, Young J, Mattingly G, Gao J, Squires L, Adler L; 304 Study Group.

CNS Spectr. 2009 Oct;14(10):573-85.

PMID:
20095369
7.

Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127).

Suppes T, Vieta E, Liu S, Brecher M, Paulsson B; Trial 127 Investigators.

Am J Psychiatry. 2009 Apr;166(4):476-88. doi: 10.1176/appi.ajp.2008.08020189. Epub 2009 Mar 16.

PMID:
19289454
8.

Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study.

Tohen M, Vieta E, Goodwin GM, Sun B, Amsterdam JD, Banov M, Shekhar A, Aaronson ST, Bardenstein L, Grecu-Gabos I, Tochilov V, Prelipceanu D, Oliff HS, Kryzhanovskaya L, Bowden C.

J Clin Psychiatry. 2008 Nov;69(11):1776-89. Epub 2008 Oct 7.

PMID:
19014751
9.

Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.

Adler LA, Goodman DW, Kollins SH, Weisler RH, Krishnan S, Zhang Y, Biederman J; 303 Study Group.

J Clin Psychiatry. 2008 Sep;69(9):1364-73. Epub 2008 Sep 9.

PMID:
19012818
10.

Effects of PRX-00023, a novel, selective serotonin 1A receptor agonist on measures of anxiety and depression in generalized anxiety disorder: results of a double-blind, placebo-controlled trial.

Rickels K, Mathew S, Banov MD, Zimbroff DL, Oshana S, Parsons EC Jr, Donahue SR, Kauffman M, Iyer GR, Reinhard JF Jr.

J Clin Psychopharmacol. 2008 Apr;28(2):235-9. doi: 10.1097/JCP.0b013e31816774de.

PMID:
18344738
11.

Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.

Tohen M, Calabrese JR, Sachs GS, Banov MD, Detke HC, Risser R, Baker RW, Chou JC, Bowden CL.

Am J Psychiatry. 2006 Feb;163(2):247-56.

PMID:
16449478
12.

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group.

Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG, Sanger T, Risser R, Zhang F, Toma V, Francis J, Tollefson GD, Breier A.

Arch Gen Psychiatry. 2000 Sep;57(9):841-9. Erratum in: Arch Gen Psychiatry 2002 Jan;59(1):91.

PMID:
10986547
13.

Clozapine in the treatment of refractory psychotic mania.

Green AI, Tohen M, Patel JK, Banov M, DuRand C, Berman I, Chang H, Zarate C Jr, Posener J, Lee H, Dawson R, Richards C, Cole JO, Schatzberg AF.

Am J Psychiatry. 2000 Jun;157(6):982-6.

PMID:
10831480
14.

Improved outcome in fluvoxamine-treated patients with SSRI-induced sexual dysfunction.

Banov MD.

J Clin Psychiatry. 1999 Dec;60(12):866-8. No abstract available.

PMID:
10665636
15.

EEG abnormalities before clozapine therapy predict a good clinical response to clozapine.

Pillay SS, Stoll AL, Weiss MK, Tohen M, Zarate CA Jr, Banov MD, Cole JO.

Ann Clin Psychiatry. 1996 Mar;8(1):1-5.

PMID:
8743641
16.

Is clozapine a mood stabilizer?

Zarate CA Jr, Tohen M, Banov MD, Weiss MK, Cole JO.

J Clin Psychiatry. 1995 Mar;56(3):108-12.

PMID:
7883728
17.

Neurologic factors predict a favorable valproate response in bipolar and schizoaffective disorders.

Stoll AL, Banov M, Kolbrener M, Mayer PV, Tohen M, Strakowski SM, Castillo J, Suppes T, Cohen BM.

J Clin Psychopharmacol. 1994 Oct;14(5):311-3.

PMID:
7806685
18.

A double-blind trial of bupropion versus desipramine for bipolar depression.

Sachs GS, Lafer B, Stoll AL, Banov M, Thibault AB, Tohen M, Rosenbaum JF.

J Clin Psychiatry. 1994 Sep;55(9):391-3.

PMID:
7929019
19.

Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up.

Banov MD, Zarate CA Jr, Tohen M, Scialabba D, Wines JD Jr, Kolbrener M, Kim JW, Cole JO.

J Clin Psychiatry. 1994 Jul;55(7):295-300.

PMID:
8071290
20.

High risk of eosinophilia in women treated with clozapine.

Banov MD, Tohen M, Friedberg J.

J Clin Psychiatry. 1993 Dec;54(12):466-9.

PMID:
8276737

Supplemental Content

Loading ...
Support Center